QGEN Volume dodolan mangsa ngarep perusahaan Qiagen NV

Qiagen (QGEN) - logo korporat

The molecular diagnostics market relies on an installed base of analyzers that generate a steady stream of revenue from consumables. The future sales volume of the company on the GURU.Markets chart reflects financial stability dynamics, where 2.99 expresses the metric's value today. Qiagen N.V. (QGEN) is recognized as the global gold standard for DNA extraction, maintaining supply chain stability amid moderately low geopolitical risks.

Qiagen N.V. - Dodolan mangsa ngarep perusahaan QGEN (periode 04.07.2022 - 18.11.2026)

QGEN (Qiagen Group): rincian analitis lan laporan miturut indikator

- rega saiki lan proyeksi nilai saham:
Analisis kabeh metrik perusahaan:QGEN Qiagen Group
Produk merek Qiagen NV

For Qiagen N.V. (QGEN), with its business model based on the sale of closed systems and consumables, this indicator reflects projected revenue by measuring the potential for customer base expansion and reagent consumption volumes. Anomalies in sales expectations for the company's products signal failures in corporate governance or a sharp shift in market demand, requiring investors to verify the operational resilience of the business.

Karo sapa Qiagen N.V. saingan

Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Prakiraan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Prakiraan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Volume dodolan sing dikarepake perusahaan|CRSP - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Twist Bioscience Corp TWST|Prakiraan volume dodolan TXG|Prakiraan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Volume dodolan mangsa ngarep perusahaan|BioLife Solutions Inc (BLFS) - Volume dodolan sing dikarepake perusahaan|wavelifesciences.com - Prakiraan volume dodolan|Maze Therapeutics Corp (MAZE) - Volume dodolan mangsa ngarep perusahaan|SION: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PRME|Prakiraan pendapatan perusahaan Taysha Gene Therapies|Prakiraan pendapatan perusahaan QURE (uniQure)|Prakiraan pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Solid Biosciences SLDB|OCGN - Volume dodolan mangsa ngarep perusahaan|pacb.com - Prakiraan volume dodolan|Benitec (BNTC) - Volume dodolan mangsa ngarep perusahaan|DSGN: Prakiraan volume dodolan|RCKT - Dodolan mangsa ngarep perusahaan|FDMT: Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan LXEO (lexeotx.com)|Prakiraan pendapatan perusahaan Korro Bio Inc. (KRRO)|Prakiraan volume pendapatan perusahaan EDIT|Prakiraan volume dodolan SLN (Silence Therapeutics PLC)|Pendapatan mangsa ngarep perusahaan PRQR|CDXS - Prakiraan pendapatan perusahaan|SGMO (Sangamo Therapeutics) - Prakiraan pendapatan perusahaan|NAUT: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan MGX|DTIL (precisionbiosciences.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GBIO (Generation Bio Co.)|Prakiraan pendapatan perusahaan Boundless Bio (BOLD)|Exicure - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IMNN (imunon.com)|Dodolan mangsa ngarep perusahaan Phio Pharmaceuticals (PHIO)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan